EUVIMEDEUVIMED entdecken
Crossref

Synergistic Analgesic and Anti-Inflammatory Effects of Kratom (Mitragyna speciosa) Leaf Extract as an Adjuvant to Paracetamol in a Rat Neuropathic Pain Model

Gusti Pindo Asa Anindito, Christrijogo Sumartono Waloejo, Prananda Surya Airlangga, Anna Surgean Veterini, Dedi Susila

International Journal of Drug Delivery Technology · 04.04.2026 · 16 (5s)

DOI: 10.25258/ijddt.16.5s.71 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 04.04.2026. Verfasst von Gusti Pindo Asa Anindito und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuropathic pain is a chronic condition with a substantial impact on quality of life. An Indonesian multicentre survey reported a neuropathic pain prevalence of 21.8%, exceeding global estimates.¹ Paracetamol is widely used for pain management, but high doses are associated with hepatotoxicity.² Kratom (Mitragyna speciosa) contains opioid like and anti inflammatory alkaloids and may serve as an adjuvant to reduce paracetamol dose.³ C X C motif chemokine ligand 1 (CXCL1) is a pro inflammatory chemokine implicated in neuropathic and inflammatory pain.⁴⁻⁶ This study evaluated the effect of kratom leaf extract as an adjuvant to paracetamol on mechanical pain threshold and serum CXCL1 levels in a chronic constriction injury (CCI) rat neuropathic pain model. Twenty eight male Wistar rats (Rattus norvegicus; 2–3 months; 150–250 g) underwent sciatic nerve CCI.⁷ Animals were randomised into four groups (n=7): negative control (placebo), paracetamol 10 mg/kg body weight (BW), paracetamol 5 mg/kgBW + kratom extract 30 mg/kgBW, and paracetamol 5 mg/kgBW + kratom extract 60 mg/kgBW. Treatments were administered orally once daily for 7 days. Mechanical pain threshold was assessed with the von Frey test at baseline, 7 days post CCI (pre treatment), and after treatment.⁸ Serum CXCL1 was measured by ELISA on day 14. Two animals (one in the paracetamol 10 mg/kgBW group and one in the paracetamol 5 mg/kgBW + kratom 30 mg/kgBW group) died during the experiment and were excluded from post treatment analysis. CCI significantly reduced von Frey thresholds compared with baseline (mean difference 6.25 ± 1.89 g; p

Zitieren

APA

Anindito, G. P. A., Waloejo, C. S., Airlangga, P. S., Veterini, A. S., & Susila, D. (2026). Synergistic Analgesic and Anti-Inflammatory Effects of Kratom (Mitragyna speciosa) Leaf Extract as an Adjuvant to Paracetamol in a Rat Neuropathic Pain Model. International Journal of Drug Delivery Technology, 16(5s). https://doi.org/10.25258/ijddt.16.5s.71

Vancouver

Anindito GPA, Waloejo CS, Airlangga PS, Veterini AS, Susila D. Synergistic Analgesic and Anti-Inflammatory Effects of Kratom (Mitragyna speciosa) Leaf Extract as an Adjuvant to Paracetamol in a Rat Neuropathic Pain Model. International Journal of Drug Delivery Technology. 2026;16(5s). doi:10.25258/ijddt.16.5s.71

BibTeX
@article{Anindito2026,
  author = {Anindito, Gusti Pindo Asa and Waloejo, Christrijogo Sumartono and Airlangga, Prananda Surya and Veterini, Anna Surgean and Susila, Dedi},
  title = {Synergistic Analgesic and Anti-Inflammatory Effects of Kratom (Mitragyna speciosa) Leaf Extract as an Adjuvant to Paracetamol in a Rat Neuropathic Pain Model},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {5s},
  doi = {10.25258/ijddt.16.5s.71}
}
Kostenlos starten →